Wimly is patient-founded, patient-led, and built to serve the rare disease community. Not backed by venture capital or pharmaceutical investment.

Honorary Professor at the University of Edinburgh (Deanery of Biomedical Sciences) and independent consultant in bioinformatics and cheminformatics. His background spans pharmaceutical R&D data infrastructure at AstraZeneca, the IUPHAR/BPS Guide to PHARMACOLOGY database at Edinburgh University, and intelligence analysis at Medicines Discovery Catapult; he advises Wimly on research data standards, data quality, and the intersection of patient-generated data with drug discovery infrastructure.

Neurologist at the Karolinska University Hospital and researcher in the Department of Clinical Neuroscience at Karolinska Institutet. His work focuses on the genetics and clinical presentation of spinocerebellar ataxias and related movement disorders; he was a lead author on the 2023 study that identified the genetic cause of SCA4.

Post-doctoral researcher at Karolinska Institutet with over eight years of experience in translational neurogenetics, focusing on repeat-expansion disorders and rare neurodegenerative diseases. His work integrates molecular assays and circRNA-based biomarkers with clinical data to advance diagnostics and disease modelling, with a specific focus on spinocerebellar ataxias and related conditions.

Neuropsychologist and PhD candidate at Lund University, where his research focuses on neurocognition in spinocerebellar ataxias and other cerebellar and neurodegenerative conditions, specifically how the cerebellum contributes to cognitive dysfunction beyond its classical role in motor control. Clinically he works at the Neurology Unit of Helsingborg Hospital, with additional experience in neuropsychiatric assessment.

Associate Professor in Neurophysiology and Senior Lecturer at Lund University, where he leads the Associative Learning research group within Cognitive Science. His research focuses on cerebellar function and motor learning, with a parallel strand of work on cerebellar involvement in ataxias, ADHD, and autism.

Adjunct Professor, consultant neurologist, and project manager of the Clinical Neurogenetics research group at Lund University. His research focuses on the genetic causes of rare movement disorders including Parkinson's disease, dystonia, and ataxia, with 129 published research outputs spanning clinical and genomic aspects of inherited neurological conditions.

Neurologist and researcher in the Clinical Neurogenetics group at Lund University, with a research focus on spinocerebellar ataxias and other rare neurological conditions. She is a co-author on the 2024 study identifying the genetic basis of SCA4 and has led clinical and genetic analyses of Swedish ataxia patient cohorts.

Statistician and Data Scientist at the Department of Clinical Sciences, Lund University, where his work focuses on statistical machine learning, real-world evidence modelling, and longitudinal prediction in medical science. He advises Wimly on the statistical architecture of the patient observation dataset, including the design of the longitudinal data model, survival and progression analysis, and the validation framework required to make patient-generated evidence credible to clinical and research partners.